Is CLMT a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Calumet (CLMT) rests on Sustainable aviation fuel volumes stepping up: The MaxSAF 150 expansion at Great Falls came online in May 2026 after a planned turnaround, lifting nameplate SAF capacity to roughly 120 to 150 million gallons a year from about 30 million. The bear case rests on leverage is the first thing to look at: roughly $2.3 billion of debt against a company that has not produced consistent GAAP profits. Analysts covering it publish targets from $26.00 to $60.00 against a $40.26 price, so even the professionals disagree by 86% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Calumet runs three reportable businesses. Specialty Products and Solutions is the historic core: solvents, waxes, white oils, petrolatums, gels, esters and customised lubricating oils sold into industrial, personal care and packaging end markets, made mostly at the Shreveport, Louisiana complex plus a handful of smaller plants. Performance Brands is the smaller but far higher margin piece, blending and packaging finished products under the Royal Purple, Bel-Ray and TruFuel names. Montana/Renewables covers the Great Falls, Montana site, where renewable feedstocks are converted into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable naphtha and renewable propane, alongside a specialty asphalt operation. For roughly two decades this was Calumet Specialty Products Partners, L.P., a master limited partnership that sent unitholders a K-1 and, until 2016, a quarterly distribution. It converted to a Delaware corporation, Calumet, Inc., in July 2024. That swap removed the K-1, made the shares eligible for index funds and institutions that cannot hold partnership units, and turned CLMT into an ordinary Nasdaq-listed common stock. The financial picture is lumpy. Trailing revenue is roughly $4.2 billion, but the company still posts large GAAP losses, about $189 million over the trailing twelve months, mostly from non-cash RIN obligations and derivative mark-to-market swings rather than cash burn. Management steers the story on Adjusted EBITDA with Tax Attributes, which was around $293 million for full-year 2025 and $50.1 million in the first quarter of 2026. Long-term debt sits near $2.3 billion against roughly $139 million of cash, though a $1.44 billion Department of Energy loan facility, whose first $782 million tranche landed in early 2025, refinanced Montana Renewables at a Treasury-plus rate and defers principal and interest until the MaxSAF expansion is commissioned. The shares moved from under $13 to roughly $40 over the past year, driven less by the specialty business than by the EPA's Set 2 renewable volume obligation rule and D4 RIN credits trading near their highest levels since 2021. That is the trade the market is currently making.

The bull case: what would have to be true for $60.00

The most optimistic published target on CLMT is $60.00, +49.0% from the $40.26 price as of August 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Sustainable aviation fuel volumes stepping up.

The MaxSAF 150 expansion at Great Falls came online in May 2026 after a planned turnaround, lifting nameplate SAF capacity to roughly 120 to 150 million gallons a year from about 30 million. Management has framed the next stage as a path toward roughly 300 million gallons by 2028, funded largely by the DOE facility. SAF sells at a premium to renewable diesel and demand is contracted by airlines under long-dated offtake, so the mix shift matters more than the headline volume.

2. Renewable fuel policy and credit economics.

The EPA finalised its Set 2 renewable volume obligations in March 2026 at the highest levels in the program's history, and D4 RIN prices responded by climbing toward $2.40 from roughly $0.41 in early 2025. The 45Z clean fuel production credit, which favours domestically produced fuel from domestic feedstock, adds a second layer. Calumet booked $22.5 million of tax credits inside the Montana segment in the first quarter alone. These are regulatory inputs, not company achievements, and they can move in either direction.

3. Specialty products as the cash floor.

Specialty Products and Solutions contributed $44.3 million and Performance Brands $12.6 million of Adjusted EBITDA with Tax Attributes in the first quarter of 2026, together more than covering unallocated corporate costs and leaving the consolidated figure at $50.1 million. These are niche formulations with long qualification cycles and sticky customers, which makes their earnings far less volatile than the renewable side. Performance Brands in particular runs consumer-style margins on a small revenue base.

4. Deleveraging and a possible Montana monetization.

Calumet cut restricted group debt by more than $220 million during 2025 and has repeatedly said the eventual goal is to monetize part of Montana Renewables to retire more. The near-term stance is to demonstrate post-expansion earnings power first and sell into a better print later. Whether that monetization happens, and at what implied value, is the single largest swing factor in how the current share price gets justified.

The bear case: what would have to be true for $26.00

The most pessimistic published target is $26.00, -35.4% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Calumet is worth if the risks below bite instead of the drivers above.

Leverage is the first thing to look at: roughly $2.3 billion of debt against a company that has not produced consistent GAAP profits. The renewable segment's economics depend on rules the company does not control, and RIN prices, RVO volumes and the 45Z credit have all been revised sharply before. Feedstock costs for renewable diesel and SAF are volatile and the crush spread can compress quickly when vegetable oil and tallow prices rise. Refinery turnarounds, unplanned outages and the remaining MaxSAF construction all carry execution risk at a company with limited balance sheet slack. The stock has roughly tripled off its 52-week low, so a good deal of the favourable policy environment is already reflected in the price, and reported results have swung between EPS beats and large EBITDA misses in the same quarter.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CLMT already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on CLMT

5 analysts cover CLMT, with an average target of $39.60 (-1.6% against $40.26) and a split of 2 buy, 4 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the CLMT forecast and price target page.

How is CLMT valued? (as of August 2026)

Price

$40.26

Market cap

$3.51B

Forward P/E

95.86

Beta

0.71

52-week range

$12.94 to $45.20

Snapshot for CLMT as of August 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (TTM): ~$4.2 billion
Net income (TTM): ~-$189 million (~-$2.17 per share)
Adjusted EBITDA with Tax Attributes (FY2025): ~$293 million
Market cap: ~$3.5 billion (~87 million shares)
Long-term debt / cash: ~$2.3 billion / ~$139 million
52-week range: ~$12.94 to ~$45.20

Standard earnings multiples do not compute here because trailing net income is negative, so the market prices CLMT on enterprise value against a forward EBITDA that assumes the new SAF capacity runs and the credit environment holds. Enterprise value is roughly $5.7 billion once the debt is added, against 2025 Adjusted EBITDA with Tax Attributes of about $293 million, a multiple that only looks reasonable if 2027 earnings power is materially higher. Note that the company's headline profitability metric includes tax credits, which is not the same thing as operating cash flow.

How do you decide if CLMT is a buy?

Rather than asking whether CLMT is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the bull case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold CLMT indirectly through an index or sector ETF before adding more.

What would change your mind on CLMT

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

Bull case breaks if: Sustainable aviation fuel volumes stepping up stalls in the reported numbers rather than in the narrative around them.
Bear case breaks if: leverage is the first thing to look at: roughly $2.3 billion of debt against a company that has not produced consistent GAAP profits fails to materialise over several reporting periods while the drivers keep compounding.
Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the CLMT stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CLMT against your real portfolio and see your actual exposure before deciding.

Investing in Calumet with AI

Connect the broker you already use and ask Walnut's AI how CLMT fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

See how it fits your portfolio

FAQ

Is CLMT a good stock to buy right now?

That depends on which case you find more convincing, and both are on this page. The bull case rests on Sustainable aviation fuel volumes stepping up, with revenue (ttm) at ~$4.2 billion. The bear case rests on leverage is the first thing to look at: roughly $2.3 billion of debt against a company that has not produced consistent GAAP profits. Analysts covering it are spread from $26.00 to $60.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell CLMT?

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Leverage is the first thing to look at: roughly $2.3 billion of debt against a company that has not produced consistent GAAP profits. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $26.00, -35.4% from the $40.26 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for CLMT?

Sustainable aviation fuel volumes stepping up. The MaxSAF 150 expansion at Great Falls came online in May 2026 after a planned turnaround, lifting nameplate SAF capacity to roughly 120 to 150 million gallons a year from about 30 million. The most optimistic analyst target on CLMT is $60.00, +49.0% from the $40.26 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for CLMT?

What does Calumet do?

Calumet produces specialty hydrocarbon products (lubricants, solvents, waxes) alongside a renewable-fuels segment at Montana Renewables, a leveraged business sensitive to crack spreads and policy credits.

What would have to change for CLMT to stop being worth holding?

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Sustainable aviation fuel volumes stepping up) stalling in the reported numbers rather than in the narrative, the risk above (leverage is the first thing to look at: roughly $2.3 billion of debt against a company that has not produced consistent GAAP profits) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Calumet, Inc. actually do?

Calumet makes specialty hydrocarbon products and renewable fuels. The specialty side produces solvents, waxes, white oils, petrolatums and esters for industrial, personal care and packaging customers, plus branded finished lubricants under Royal Purple, Bel-Ray and TruFuel. The renewable side is the Great Falls, Montana plant, which turns waste fats, used cooking oil and vegetable oils into renewable diesel and sustainable aviation fuel, and also runs a specialty asphalt operation.

Why did Calumet convert from a partnership to a corporation?

Until July 2024 this was Calumet Specialty Products Partners, L.P., a master limited partnership. MLP units generate a K-1 tax form instead of a 1099, which many retail investors dislike, and most index funds, mutual funds and retirement accounts either cannot hold them or face tax complications if they do. Converting to Calumet, Inc., a Delaware corporation, removed those obstacles, broadened the potential shareholder base and simplified the capital structure ahead of the Montana Renewables financing.

Does CLMT pay a dividend?

No. The predecessor partnership suspended its distribution back in 2016 during a period of financial stress, and the converted corporation has not reinstated a payout. Free cash is being directed at debt reduction and the MaxSAF expansion instead. Anyone who remembers CLMT as a high-yield MLP should treat that as history: the current shareholder return case rests entirely on deleveraging and earnings growth, not on income.

Walnut is informational, not investment advice, and gives no verdict on CLMT. Analyst targets referenced here come from a August 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.